Effects of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity, blood pressure and heart rate in anaesthetized rats and cats
- PMID: 3987812
- DOI: 10.1016/0014-2999(85)90210-9
Effects of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity, blood pressure and heart rate in anaesthetized rats and cats
Abstract
The influence of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity was determined in anaesthetized cats and rats. The effects of these drugs on blood pressure and heart rate were also evaluated. Impulse output was recorded in the splanchnic and vagus nerve of the cat, and in the cervical sympathetic trunk of the rat. Urapidil increased activity in sympathetic and parasympathetic nerve fibres in cats at low doses without affecting blood pressure and heart rate. At higher doses which lowered blood pressure, urapidil reduced sympathetic impulse output in cats and rats while vagal output was increased. The alpha 1-adrenoceptor blocking agent, prazosin, did not affect activity in sympathetic and parasympathetic nerve fibres while the beta-adrenoceptor blocking agent, propranolol, increased activity in these nerves in cats. The alpha-adrenoceptor agonist, clonidine, reduced sympathetic impulse output at all doses tested in both rats and cats. The results provide evidence that urapidil, in addition to its peripheral alpha- and beta-adrenoceptor blocking properties, affects cardiovascular regulation by a central action. Blockade of alpha- or beta-adrenoceptors in the brain is probably not responsible for the central effect of urapidil.
Similar articles
-
Effect of urapidil, clonidine, and prazosin on sympathetic tone in conscious rats.Hypertension. 1986 Apr;8(4):303-11. doi: 10.1161/01.hyp.8.4.303. Hypertension. 1986. PMID: 3957416
-
Comparative effects of urapidil, prazosin, and clonidine on ligand binding to central nervous system receptors, arterial pressure, and heart rate in experimental animals.Am J Med. 1984 Oct 5;77(4A):87-95. doi: 10.1016/s0002-9343(84)80042-x. Am J Med. 1984. PMID: 6091452
-
The mechanism of the sympathoinhibitory action of urapidil: role of 5-HT1A receptors.Br J Pharmacol. 1991 Apr;102(4):998-1002. doi: 10.1111/j.1476-5381.1991.tb12290.x. Br J Pharmacol. 1991. PMID: 1855130 Free PMC article.
-
Pharmacologic profile of urapidil.Am J Cardiol. 1989 Aug 15;64(7):1D-6D. doi: 10.1016/0002-9149(89)90687-5. Am J Cardiol. 1989. PMID: 2569262 Review.
-
The central action of antihypertensive drugs, mediated via central alpha-receptors.J Pharm Pharmacol. 1973 Feb;25(2):89-95. doi: 10.1111/j.2042-7158.1973.tb10599.x. J Pharm Pharmacol. 1973. PMID: 4146560 Review. No abstract available.
Cited by
-
Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.Br J Pharmacol. 1988 Nov;95(3):975-85. doi: 10.1111/j.1476-5381.1988.tb11728.x. Br J Pharmacol. 1988. PMID: 3207999 Free PMC article.
-
Urapidil and some analogues with hypotensive properties show high affinities for 5-hydroxytryptamine (5-HT) binding sites of the 5-HT1A subtype and for alpha 1-adrenoceptor binding sites.Naunyn Schmiedebergs Arch Pharmacol. 1987 Dec;336(6):597-601. doi: 10.1007/BF00165749. Naunyn Schmiedebergs Arch Pharmacol. 1987. PMID: 2832770
-
Experimental studies on the neurocardiovascular effects of urapidil.Drugs. 1988;35 Suppl 6:20-33. doi: 10.2165/00003495-198800356-00004. Drugs. 1988. PMID: 2900129
-
Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.Drugs. 1989 Dec;38(6):900-40. doi: 10.2165/00003495-198938060-00005. Drugs. 1989. PMID: 2693046 Review.
-
Human pharmacology of urapidil.Drugs. 1988;35 Suppl 6:34-9. doi: 10.2165/00003495-198800356-00005. Drugs. 1988. PMID: 3042359 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous